Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Middle East Respiratory Syndrome
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Filter
Condition:
COVID-19
Journal:
Indian journal of pharmacology
Treatment Used:
Steroid Therapy
Number of Patients:
NULL
Published —
March 05, 2021
In this study, researchers evaluated the safety and effectiveness of steroid therapy for the treatment of COVID-19.
Condition:
Coronavirus Infection
Journal:
Kardiologiia
Treatment Used:
Bromhexine and Spironolactone
Number of Patients:
103
Published —
January 25, 2021
This study evaluated the effectiveness and safety of bromhexine (medication that is used to treat chest congestion and cough) and spironalactone (used to treat high blood pressure and heart failure) in patients with coronavirus (a pandemic infection caused by a coronavirus) infection requiring hospitalization.
Condition:
Patients with Diabetes Amidst the Covid-19 Pandemic
Journal:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Treatment Used:
Probiotics
Number of Patients:
0
Published —
January 20, 2021
This review of the literature examined data concerning gut microbiota influences on COVID-19 in patients with diabetes.
Condition:
Viral Respiratory Infections
Journal:
BMJ open
Treatment Used:
Non-Steroidal Anti-Inflammatory Drugs
Number of Patients:
NULL
Published —
January 14, 2021
The study researched the use of non-steroidal anti-inflammatory drugs in patients with viral respiratory infections.
Condition:
COVID-19
Journal:
International immunopharmacology
Treatment Used:
Convalescent Plasma (CP)
Number of Patients:
0
Published —
December 18, 2020
This review of the literature evaluated the use of convalescent plasma (CP) in the treatment of patients with COVID-19.
Condition:
Rheumatologic Disorders During COVID-19 Pandemic
Journal:
Reumatismo
Treatment Used:
Biological Therapy
Number of Patients:
1
Published —
November 20, 2020
This case report describes a 40-year-old man with a history of rheumatoid arthritis treated with prednisolone, disease-modifying anti-rheumatic Drugs (DMARDs), and biologic agents diagnosed with COVID-19 treated with supportive care, lopinavir/ritonavir 400/100 mg twice daily, oseltamivir (75 mg) twice daily, hydroxychloroquine (400 mg), decreased methotrexate, and continued azathioprine and adalimumab.
Condition:
COVID-19
Journal:
The American journal of Chinese medicine
Treatment Used:
Glycyrrhizin
Number of Patients:
NULL
Published —
November 17, 2020
In this study, researchers evaluated the outcomes of using glycyrrhizin for the treatment of COVID-19.
Condition:
Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome
Journal:
Critical care (London, England)
Treatment Used:
Corticosteroid Therapy
Number of Patients:
382
Published —
November 11, 2020
This study compared the risk of death between patients with COVID-19-related-acute respiratory distress syndrome treated with corticosteroid treatment and those without.
Condition:
QT Interval in Patients With COVID-19
Journal:
Kardiologiia
Treatment Used:
Azithromycin and Hydroxychloroquine
Number of Patients:
0
Published —
November 06, 2020
This article discusses the potential risks involving the QT interval related to the drug treatment of COVID-19 with azithromycin and hydroxychloroquine.
Condition:
COVID-19
Journal:
Scientific reports
Treatment Used:
Tocilizumab
Number of Patients:
274
Published —
November 06, 2020
This study assessed the use of tocilizumab in COVID-19 patients with cytokine storm and determined the effect on mortality.
Condition:
Hospitalized Frail Elderly COVID-19 Patients
Journal:
Nutrients
Treatment Used:
Vitamin D Supplementation
Number of Patients:
77
Published —
November 05, 2020
This study determined whether bolus vitamin D supplementation before or after COVID-19 infection was effective in improving survival among hospitalized frail elderly patients.
Condition:
COVID-19
Journal:
International journal of clinical pharmacology and therapeutics
Treatment Used:
Oral Polyvalent Immunoglobulins
Number of Patients:
NULL
Published —
November 03, 2020
The study researched the outcomes of using oral polyvalent immunoglobulins for COVID-19.
Showing 1-12 of 966
Next